Investing in national AIDS strategies would yield returns, analysis says

0
268
Since almost 75 percent of costs are attributable to antiretroviral drug treatment, reducing the price of those drugs could lead to even greater cost

Healthcarecare Finance News Feed

LEAVE A REPLY